Effects of dietary L-carnitine supplementation on the response to an inflammatory challenge in mid-lactating dairy cows: hepatic mRNA abundance of genes involved in fatty acid metabolism
Description
Supplemental Figure S1. (A) Milk yield, (B) dry matter intake (DMI), and (C) net energy balance (EB) in cows fed non-supplemented (Control) or an L-carnitine-supplemented diet (Carnitine). Data are given as LS-means ± SE. Data for milk yield, DMI, and EB are from Meyer et al. (2021). Supplemental Figure S2. Blood concentrations of (A) insulin, (B) glucose, (C) ß-hydroxybutyrate (BHB), (D) fatty acids (FA) in cows fed non-supplemented (Control) or an L-carnitine-supplemented diet (Carnitine). Data are given as LS-means ± SE. Data for insulin, glucose, BHB, and FA are from Meyer et al. (2021). Supplemental Figure S3. Volcano plot visualizing the hepatic mRNA abundance of genes in cows fed non-supplemented (CON, n = 21) compared to those fed L-carnitine supplemented (CAR, n = 22) diets on d +14 relative to the LPS administration. The x-axis represents the mean of log2 fold-change (FC = 1.5) value, and the y-axis corresponds to the negative logarithm of the P-values (FDR = 0.05). Each dot represents a single mRNA.